CMS proposes in 428.202(g)(1) to codify the policy described in section 40.1.2 of the revised Medicare Part D Drug Inflation Rebate Guidance, whereby in cases where there are 1 or more quarter(s) in the payment amount benchmark period or applicable period for which a manufacturer has not reported units under section 1927(b)(3)(A)(iv) of the Act but has reported AMP under sections 1927(b)(3)(A)(i) and (ii) of the Act, CMS would calculate the benchmark period manufacturer price or AnMP, as applicable, using data only from quarter(s) with units
Al-Safi SA, Ayoub NM, MbA A, Al-Doghim I, Aboul-Enein FH
They say quitting smoking can be a challenge, but medical aids such as nicotine patches, as well as support from friends, can help
The coarse abrasives in tobacco products when constantly chewed cause abrasion or tooth wear
The ideal treatment for a patient depends on many factors including the stage at which the cancer is diagnosed, the patients age, overall health, and personal preferences